Effects of Different Telerehabilitation Methods on Pain, Functional Limitation, Muscle Strength, Balance, and Quality of Life in Patients With Meniscus Degeneration
Comparison of the Effects of Different Telerehabilitation Methods on Pain, Functional Limitation, Muscle Strength, Balance, and Quality of Life in Patients With Meniscus Degeneration
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Our study will include 60 patients diagnosed with meniscus degeneration in the Department of Physiotherapy and Rehabilitation of the Faculty of Health Sciences of Marmara University. Volunteers will be informed about the purpose of the study and the evaluations and treatments to be carried out, and their consent will be obtained by reading the 'Informed Volunteer Consent Form' and obtaining their signatures. The sample group and distribution will be determined as 30 asynchronous telerehabilitation groups and 30 synchronous telerehabilitation groups. Our study is a randomized controlled trial. Groups will be formed in a randomized manner and blinded study design will be used to evaluate outcome parameters. Patients beginning the rehabilitation program will be evaluated at the start of the study, at week 4, week 8, and week 16. Demographic information of the patients participating in the study will be obtained using the demographic data form. Visual Analogue Scale (VAS) for pain, WOMET index for functionality and quality of life, functionality with Lysholm Knee Scoring Scale and quality of life with Patient Generated Index (PGI) and Short Form-12 (SF-12) scales; Functional mobility Timed Up and Go Test (TUG), functional capacity 2 Minutes Walk Test (2 MWT), balance Balance Master, proprioception and muscle strength Isokinetic assessment device, lower extremity neuromuscular function level 30 sec Sit Up and 5 Sit \& Go performance tests will be evaluated with Our study will investigate the comparison of the effects of asynchronous and synchronous telerehabilitation programs on pain, functional limitation, muscle strength and quality of life in patients with meniscal degeneration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 8, 2022
CompletedFirst Submitted
Initial submission to the registry
August 12, 2022
CompletedFirst Posted
Study publicly available on registry
August 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2023
CompletedAugust 15, 2022
August 1, 2022
5 months
August 12, 2022
August 12, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
The Lysholm score
The Lysholm score is a 100-point scoring system for examining a patient's knee-specific symptoms including mechanical locking, instability, pain, swelling, stair climbing, and squatting.
The The Lysholm score will be measured at baseline 2 minutes after pain assessment.
The Lysholm score
The Lysholm score is a 100-point scoring system for examining a patient's knee-specific symptoms including mechanical locking, instability, pain, swelling, stair climbing, and squatting.
The The Lysholm score will be measured at the end of intervention (8. week) 2 minutes after pain assessment.
Visual analogue scale (VAS)
Pain will be measured using a 10 cm visual analogue scale (VAS). The participants places a mark on the line that best represented their perception of pain at that instant. The VAS score will be measured in cm from the left hand end of the line to the mark.
The pain will be measured at baseline
Visual analogue scale (VAS)
Pain will be measured using a 10 cm visual analogue scale (VAS). The participants places a mark on the line that best represented their perception of pain at that instant. The VAS score will be measured in cm from the left hand end of the line to the mark.
The pain will be measured at the end of intervention (8. week).
Secondary Outcomes (8)
12-Item Short Form Survey (SF-12)
The SF-12 will be measured at baseline 2 minutes after The Lysholm score assessment.
12-Item Short Form Survey (SF-12)
The SF-12 will be measured at the end of intervention (8. week) 2 minutes after The Lysholm score assessment.
30 Seconds Sit To Stand Test
The 30 Seconds Sit To Stand Test will be measured at baseline 2 minutes after SF-12 assessment.
30 Seconds Sit To Stand Test
The 30 Seconds Sit To Stand Test will be measured at the end of intervention (8. week) 2 minutes after SF-12 assessment.
2 Minute Walk Test
The 2 Minute Walk Test will be measured at baseline 5 minutes after 30 Seconds Sit To Stand Test assessment.
- +3 more secondary outcomes
Study Arms (2)
Synchronous Telerehabilitation Group
ACTIVE COMPARATORSynchronous Telerehabilitation Group will receive exercise therapy via video conference.
Asynchronous Telerehabilitation Group
EXPERIMENTALAsynchronous Telerehabilitation Group will receive exercise therapy via mobile application.
Interventions
The intervention will include the different levels of the following exercises that are given to the patient considering their functional level: Straight leg raise (Level 1-2-3) Quadriceps strengthening (Level 1-2-3) Hip abductor/adductor strengthening (Level 1-2-3) Hamstring stretch Gastrocnemius stretch
The intervention will include the different levels of the following exercises that are given to the patient considering their functional level: Straight leg raise (Level 1-2-3) Quadriceps strengthening (Level 1-2-3) Hip abductor/adductor strengthening (Level 1-2-3) Hamstring stretch Gastrocnemius stretch
Eligibility Criteria
You may qualify if:
- Pain less than or equal to 7 according to VAS
- Individuals aged 18-65
- Patients with independent mobility
You may not qualify if:
- Patients who have undergone surgery in the last 1 year
- Patients who have undergone total knee replacement or total hip replacement surgery
- Patients with acute trauma in the last 1 year
- Patients with uncontrolled chronic disease
- Patients who have received physical therapy in the last 6 months
- Patients who have received hyaluronic acid and corticosteroid injections in the last 6 months
- Patients with a respiratory condition that interferes with walking will not be included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
August 12, 2022
First Posted
August 15, 2022
Study Start
August 8, 2022
Primary Completion
December 27, 2022
Study Completion
April 15, 2023
Last Updated
August 15, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share